pISSN 1226-6051
eISSN 2508-786X

Table. 2.

Table. 2.

Summary of assessment aspects of medication use review (MUR) tools

Explicit/implicit Tool name Independent of diagnosis Dosage Duration of therapy Duplication Omission Disease-Drug interaction Drug-Drug interaction Alternatives therapies Be used with Caution Renal dosage
Explicit TIME 20) O O O - O O O - - O
Explicit Beers criteria 17) O O - - - O O - O O
Explicit ES-PIA 21) O O - - O O O O - O
Explicit FORTA 22) O O O - O O - - - -
Explicit HEDIS 23) O O - - - O - - - -
Explicit Taiwan list 24) O - - - - O O O - O
Explicit Chinese criteria 25) O - - - - O O O O -
Explicit EURO-FORTA 27) O O O - O O - - - -
Explicit GheOP3S-renal 28) O O - - - - - O O O
Explicit Korean 2018 29) O - O - - O O - - -
Explicit Brazilian list 30,31) O - - - - O - O - -
Explicit STOPP-J 31) O O O O O O O O O -
Explicit Beers Alternatives 33) O - - - - O - O - -
Explicit EU-(7) PIM 34) O O O - - - - O - O
Explicit GheOP.3S tool 35) O - O - O O O O - -
Explicit Korean 2015 36) O - - - - O - O - -
Explicit STOPP/START version 2 37) O O O - O O O O - -
Explicit RASP list 38) O - O O - - O - - O
Explicit OPTI-SCRIPT 39) O O O - O O O - - -

TIME, Turkish Inappropriate Medication use in the Elderly; FORTA, Fit fOR The Aged; COS, Core Outcome Set; GheOP3S, The Ghent Older People’s Prescription community Pharmacy Screening; STOPP, Screening Tool of Older Person’s Prescriptions; EU, The European Union; START, Screening Tool to Alert doctors to Right Treatment, RASP, Rationalization of home medication by an Adjusted STOPP list in older Patients; ARMOR, Assess, Review, Minimize, Optimize, Reassess; MRQ, Medication-Risk Questionnaire

Korean J Clin Pharm 2021;31:61-78 https://doi.org/10.24304/kjcp.2021.31.1.61
© 2021 Korean J Clin Pharm